Corbion NV (NL:CRBN)
:CRBN
Want to see NL:CRBN full AI Analyst Report?
CRBN Stock Chart & Stats
€18.78
-€0.72(-3.46%)
At close: 4:00 PM EST
€18.78
-€0.72(-3.46%)
Day’s Range― - ―
52-Week Range€16.16 - €21.64
Previous CloseN/A
Volume184.39K
Average Volume (3M)126.91K
Market Cap
€1.14B
Enterprise Value€1.60B
Total Cash (Recent Filing)€44.70M
Total Debt (Recent Filing)€481.10M
Price to Earnings (P/E)15.3
Beta0.86
Next Earnings
Aug 13, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield3.5%
Share Statistics
EPS (TTM)1.29
Shares Outstanding58,250,310
10 Day Avg. Volume117,838
30 Day Avg. Volume126,914
Financial Highlights & Ratios
PEG Ratio-0.24
Price to Book (P/B)1.45
Price to Sales (P/S)0.85
P/FCF Ratio11.62
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€22.37Price Target Upside19.10% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
EPS Forecast (FY)1.39
Revenue Forecast (FY)€1.28B
Bulls Say, Bears Say
Bulls Say
Deleveraging / Balance Sheet ImprovementCorbion materially reduced debt while equity remained solid (~€743m in 2025). Lower leverage reduces interest burden and default risk, improving financial flexibility to fund capex, dividends or selective M&A and strengthening resilience over the coming months.
Sustained Cash Generation & FCF RecoveryConsistent positive operating cash flow and a recovery to positive free cash flow after earlier deficits signal improved cash discipline. This durable cash generation supports reinvestment, debt reduction and shareholder payouts without relying on external financing.
Defensive, Sustainable Business ModelCorbion's focus on sustainable food ingredients, antimicrobials and biobased chemicals targets durable end markets where customers value quality and regulatory compliance. Sticky B2B relationships and structural demand for bio-based inputs support long-term revenue resilience.
Bears Say
Multi-year Revenue DeclinePersistent top-line weakness reduces scale benefits and constrains margin expansion and reinvestment capacity. Continued revenue declines signal demand challenges in key end markets, making it harder to restore durable organic growth over the next several quarters.
Earnings And Profitability VolatilityInconsistent net income indicates earnings are reliant on one-offs or uneven margin drivers. Profit volatility undermines predictability for cash returns, budgeting and capital allocation, and weakens confidence in sustained profitability across business cycles.
Free Cash Flow Variability Constrains FlexibilityWhile FCF recovered overall, year-to-year swings and a decline in 2025 limit financial flexibility. Variability increases the risk that short-term shocks force trade-offs between debt reduction, capex and dividends, reducing strategic optionality in the medium term.
Corbion NV News
CRBN FAQ
What was Corbion NV’s price range in the past 12 months?
Corbion NV lowest stock price was €16.16 and its highest was €21.64 in the past 12 months.
What is Corbion NV’s market cap?
Corbion NV’s market cap is €1.14B.
When is Corbion NV’s upcoming earnings report date?
Corbion NV’s upcoming earnings report date is Aug 13, 2026 which is in 62 days.
How were Corbion NV’s earnings last quarter?
Corbion NV released its earnings results on Feb 26, 2026. The company reported €0.56 earnings per share for the quarter, beating the consensus estimate of N/A by €0.56.
Is Corbion NV overvalued?
According to Wall Street analysts Corbion NV’s price is currently Undervalued.
Does Corbion NV pay dividends?
Corbion NV pays a Annually dividend of €1 which represents an annual dividend yield of 3.5%. See more information on Corbion NV dividends here
What is Corbion NV’s EPS estimate?
Corbion NV’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Corbion NV have?
Corbion NV has 58,250,310 shares outstanding.
What happened to Corbion NV’s price movement after its last earnings report?
Corbion NV reported an EPS of €0.56 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.063%.
Which hedge fund is a major shareholder of Corbion NV?
Currently, no hedge funds are holding shares in NL:CRBN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Corbion NV
Corbion N.V. is a global entity specializing in the provision of a broad spectrum of ingredients, encompassing lactic acid and its derivatives, emulsifiers, functional enzyme mixtures, minerals, vitamins, and components sourced from algae. These innovative ingredient solutions, all derived from renewable resources, cater to diverse sectors such as the food industry, home and personal care, pharmaceuticals, animal feed, medical device manufacturing, and bioplastics. The company facilitates the distribution of its offerings through an extensive international network of sales offices and independent distributors. Established in 1919, the organization, formerly known as CSM N.V., officially adopted the name Corbion N.V. in October 2013, and its corporate base is located in Amsterdam, the Netherlands.
CRBN Stock 12 Month Forecast
Average Price Target
€22.37
▲(19.10% Upside)
Technical Analysis
Options Prices
Currently, No data available
---